(Q45249759)

English

Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack

scientific article published in March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

0 references

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Juhasz G

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Zsombok T

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Jakab B

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Nemeth J

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Szolcsanyi J

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

179-183

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

The pharmacodynamics of sumatriptan in nitroglycerin-induced headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Neuropeptides in migraine and cluster headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

The effects on the central nervous system of nitroglycerin--putative mechanisms and mediators.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

CGRP may play a causative role in migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00836.X

21 January 2018

Identifiers

10.1111/J.1468-2982.2005.00836.X

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45249759&oldid=2071330589"